The world has become the only coronavirus in recent weeks. It is everyone’s common desire that the efforts to stop the virus, which has spread to many countries after being seen in China, to stop the virus. New information about the coronavirus, which is reported to exceed 1 million cases and 55 thousand deaths, has come from Moderna today. Today, Moderna has released a medical timeline with information about the stages of the candidate coronavirus vaccine named ‘mRNA-1273’. It was reported that the officials from China, where the virus was first seen, revealed the genetic sequence of the virus called COVID-19 to the world, and that the US National Institute of Health (NIH) and Moderna formed the genetic sequence of mRNA-1273. According to the statement, the US National Institute of Health has started Phase 1 clinical trials of the vaccine candidate on 24 February. On March 4, the U.S. Food and Drug Administration (FDA), which examined the application of the vaccine, approved the continuation of clinical trials. Testing begins with volunteers: According to the information received from Moderna on March 23, it was said that the vaccine that the studies are continuing can only be ready between 12/18 months. On March 27, the US National Institute of Health stated that the vaccine candidate developed by Moderna will be tried on healthy volunteers. Let’s add that the volunteers to be used for vaccine testing range from 18 to 55 years old. This new information has been a source of hope for millions of people who are waiting for information about the treatment. Today, the number of people infected by the virus and casualties continue to increase. Among the countries with the highest number of cases, the USA takes the lead. Turkey ranks 10th in the list of cases. Italy lost 13.915 deaths at the top of the list in loss of life. news about Turkey if the least number of death before the Minister of Health, according to data released by Fahrettin Koca 425. The updated information and treatment studies will continue to convey to you.
